![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Cazzola M. Centanni S. Regorda C. di Marco F. di Perna F. Carlucci P. Boveri B. Santus P.
Publisher: Academic Press
ISSN: 1094-5539
Source: Pulmonary Pharmacology & Therapeutics, Vol.14, Iss.1, 2001-01, pp. : 41-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Cazzola M. Marco F.D. Santus P. Boveri B. Verga M. Matera M.G. Centanni S.
Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide/formoterol breathes QOL back into COPD patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. :